Physician

Geoffrey Fung-Soon Lim, M.D.

According to 2025 Medicare claims, Geoffrey Lim, M.D. (NPI: 1013335751) practices dermatology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is ZITELLI & BRODLAND PC (NPI: 1184790099; TIN: 251549973) and primary practice location at 15232-1312.

Lim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 703 traditional Medicare patients, billed 4,346 HCPCS/CPT codes, and received $729,841 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 106 prescription claims across 76 beneficiaries totaling $2,426 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 7 records totaling $335. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $71,919 to $729,841. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,254 and ending at $2,426. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$365K$730K2019 Medicare payment: $71,919 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $281,362 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $327,699 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $253,217 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $136,191 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $729,841 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201980324$71,919
20202531,264$281,362
20213211,482$327,699
20222891,093$253,217
2023201760$136,191
20247034,346$729,841

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$28K$57K2015 Drug cost: $5,254 (USD; Tot_Drug_Cst)2016 Drug cost: $6,497 (USD; Tot_Drug_Cst)2017 Drug cost: $56,550 (USD; Tot_Drug_Cst)2019 Drug cost: $1,029 (USD; Tot_Drug_Cst)2020 Drug cost: $3,626 (USD; Tot_Drug_Cst)2021 Drug cost: $3,207 (USD; Tot_Drug_Cst)2022 Drug cost: $1,855 (USD; Tot_Drug_Cst)2023 Drug cost: $1,109 (USD; Tot_Drug_Cst)2024 Drug cost: $2,426 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152953$5,254
20163157$6,497
20173272$56,550
2018N/RN/RN/R
20191427$1,029
20204693$3,626
20216296$3,207
20223960$1,855
20232937$1,109
202476106$2,426

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks450608$430
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more182231$88
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more207207$78
88331Pathology examination of specimen during surgery, first tissue block210435$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more304403$63

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil24666$1,650
Clobetasol PropionateClobetasol Propionate14346$261
KetoconazoleKetoconazole17476$188
Doxycycline HyclateDoxycycline Hyclate11120$85
Triamcinolone AcetonideTriamcinolone Acetonide17426$76

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$335ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Geoffrey Fung-Soon Lim, M.D.?

Tedicare shows public-source Medicare data for Geoffrey Fung-Soon Lim, M.D. (NPI 1013335751), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Geoffrey Fung-Soon Lim, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Geoffrey Fung-Soon Lim, M.D.?

Geoffrey Fung-Soon Lim, M.D. is linked to ZITELLI & BRODLAND PC (billing NPI 1184790099) in the available physician profile data.

Does Geoffrey Fung-Soon Lim, M.D. have Open Payments data?

Geoffrey Fung-Soon Lim, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.